Retraction in part: A genomic approach to identify molecular pathways associated with chemotherapy resistance.
Publication
, Journal Article
Riedel, RF; Porrello, A; Pontzer, E; Chenette, EJ; Hsu, DS; Balakumaran, B; Potti, A; Nevins, J; Febbo, PC
Published in: Mol Cancer Ther
May 2012
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Mol Cancer Ther
DOI
EISSN
1538-8514
Publication Date
May 2012
Volume
11
Issue
5
Start / End Page
1214 / 1215
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1115 Pharmacology and Pharmaceutical Sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Riedel, R. F., Porrello, A., Pontzer, E., Chenette, E. J., Hsu, D. S., Balakumaran, B., … Febbo, P. C. (2012). Retraction in part: A genomic approach to identify molecular pathways associated with chemotherapy resistance. Mol Cancer Ther, 11(5), 1214–1215. https://doi.org/10.1158/1535-7163.MCT-12-0210
Riedel, Richard F., Alessandro Porrello, Emily Pontzer, Emily J. Chenette, David S. Hsu, Bala Balakumaran, Anil Potti, Joseph Nevins, and Phillip C. Febbo. “Retraction in part: A genomic approach to identify molecular pathways associated with chemotherapy resistance.” Mol Cancer Ther 11, no. 5 (May 2012): 1214–15. https://doi.org/10.1158/1535-7163.MCT-12-0210.
Riedel RF, Porrello A, Pontzer E, Chenette EJ, Hsu DS, Balakumaran B, et al. Retraction in part: A genomic approach to identify molecular pathways associated with chemotherapy resistance. Mol Cancer Ther. 2012 May;11(5):1214–5.
Riedel, Richard F., et al. “Retraction in part: A genomic approach to identify molecular pathways associated with chemotherapy resistance.” Mol Cancer Ther, vol. 11, no. 5, May 2012, pp. 1214–15. Pubmed, doi:10.1158/1535-7163.MCT-12-0210.
Riedel RF, Porrello A, Pontzer E, Chenette EJ, Hsu DS, Balakumaran B, Potti A, Nevins J, Febbo PC. Retraction in part: A genomic approach to identify molecular pathways associated with chemotherapy resistance. Mol Cancer Ther. 2012 May;11(5):1214–1215.
Published In
Mol Cancer Ther
DOI
EISSN
1538-8514
Publication Date
May 2012
Volume
11
Issue
5
Start / End Page
1214 / 1215
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1115 Pharmacology and Pharmaceutical Sciences
- 1112 Oncology and Carcinogenesis